Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Inozyme Pharma, Inc. | SVP, CFO | Common Stock | 30.4K | $109K | $3.57 | Sep 29, 2023 | Direct |
Ocugen, Inc. | Chief Financial Officer | Common Stock | 161K | $105K | $0.65 | Jan 3, 2022 | Direct |
Ocugen, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 454K | Jan 3, 2022 | Direct | ||
Inozyme Pharma, Inc. | SVP, CFO | Stock Option (right to buy) | 165K | Mar 13, 2024 | Direct | ||
Ocugen, Inc. | Chief Financial Officer | Option(Right toBuy) | 71.1K | Dec 16, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
INZY | Inozyme Pharma, Inc. | Mar 13, 2024 | 1 | $0 | 4 | Mar 15, 2024 | SVP, CFO |
INZY | Inozyme Pharma, Inc. | Sep 29, 2023 | 1 | $8.28K | 4 | Oct 3, 2023 | SVP, CFO |
INZY | Inozyme Pharma, Inc. | Mar 31, 2023 | 1 | $2.16K | 4 | Apr 4, 2023 | SVP, CFO |
INZY | Inozyme Pharma, Inc. | Mar 23, 2023 | 1 | $0 | 4 | Mar 27, 2023 | SVP, CFO |
INZY | Inozyme Pharma, Inc. | Apr 19, 2022 | 1 | $100K | 4 | Apr 20, 2022 | SVP, CFO |
INZY | Inozyme Pharma, Inc. | Mar 21, 2022 | 1 | $0 | 4 | Mar 22, 2022 | SVP, CFO |
INZY | Inozyme Pharma, Inc. | Mar 21, 2022 | 0 | $0 | 3 | Mar 22, 2022 | SVP, CFO |
OCGN | Ocugen, Inc. | Jan 3, 2022 | 2 | $0 | 4 | Jan 5, 2022 | Chief Financial Officer |
OCGN | Ocugen, Inc. | Dec 16, 2021 | 1 | $0 | 4 | Dec 17, 2021 | Chief Financial Officer |
OCGN | Ocugen, Inc. | Nov 16, 2021 | 1 | $0 | 4 | Nov 18, 2021 | Chief Financial Officer |
OCGN | Ocugen, Inc. | Oct 26, 2021 | 1 | -$111K | 4 | Oct 27, 2021 | Chief Financial Officer |
OCGN | Ocugen, Inc. | Oct 15, 2021 | 3 | -$62.1K | 4 | Oct 15, 2021 | Chief Financial Officer |
OCGN | Ocugen, Inc. | Aug 16, 2021 | 3 | -$206K | 4 | Aug 18, 2021 | Chief Financial Officer |
OCGN | Ocugen, Inc. | Jul 15, 2021 | 3 | -$198K | 4 | Jul 16, 2021 | Chief Financial Officer |
OCGN | Ocugen, Inc. | Jun 15, 2021 | 3 | -$206K | 4 | Jun 17, 2021 | Chief Financial Officer |
OCGN | Ocugen, Inc. | May 14, 2021 | 3 | -$243K | 4 | May 14, 2021 | Chief Financial Officer |